刘宸佑

学术任务

日期	时间	会场	任务类型	Session	题目
2025-11-23	08:50-08:58	5楼中华C(5楼中华C)	论文发言	论文交流（英文）7	Atezolizumab-Bevacizumab Versus Sintilimab-Bevacizumab Biosimilar Combined With Transarterial Chemoembolization for Unresectable Hepatocellular Carcinoma: A Multicenter Real-World Comparative and Cost-Effectiveness Analysis
2025-11-23	09:20-09:28	5楼中华C(5楼中华C)	论文发言	论文交流（英文）8	Transarterial Chemoembolization Combined with Systemic Therapy in Patients with Unresectable Hepatocellular Carcinoma and Child-Pugh B7